Calamos Advisors’s STAAR Surgical STAA Stock Holding History

Calamos Advisors’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-59,143	Closed	-$4.17M	–	1315
2022 Q3	$4.17M	Buy	+59,143	New	+$5.06M	0.02%	749
2021 Q4	–	Sell	-45,599	Closed	-$5.86M	–	1163
2021 Q3	$5.86M	Buy	45,599 +26,367	+137%	+$3.69M	0.03%	566
2021 Q2	$2.93M	Buy	+19,232	New	+$2.53M	0.01%	665
2020 Q3	–	Sell	-65,255	Closed	-$4.02M	–	744
2020 Q2	$4.02M	Buy	+65,255	New	+$2.67M	0.03%	491
2016 Q3	–	Sell	-41,100	Closed	-$226K	–	627
2016 Q2	$226K	Sell	41,100 -17,200	-30%	-$111K	﹤0.01%	587
2016 Q1	$431K	Sell	58,300 -9,900	-15%	-$67K	﹤0.01%	556
2015 Q4	$487K	Sell	68,200 -9,000	-12%	-$72.9K	﹤0.01%	578
2015 Q3	$599K	Hold	77,200	–	–	﹤0.01%	580
2015 Q2	$746K	Hold	77,200	–	–	﹤0.01%	562
2015 Q1	$574K	Hold	77,200	–	–	﹤0.01%	581
2014 Q4	$703K	Buy	77,200 +19,600	+34%	+$190K	﹤0.01%	571
2014 Q3	$612K	Buy	57,600 +12,680	+28%	+$151K	﹤0.01%	563
2014 Q2	$755K	Buy	44,920 +14,245	+46%	+$234K	﹤0.01%	556
2014 Q1	$577K	Buy	+30,675	New	+$494K	﹤0.01%	571

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EFM

E Fund Management Guangzhou, China $3.37B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Calamos Advisors's STAA Position: Q4 2022 in Review

Calamos Advisors sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 59,143 shares — an estimated $4.17M sold.

Calamos Advisors first reported a position in STAA in Q1 2014 and held it in 14 quarters. The position peaked at $5.86M in Q3 2021. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

Calamos Advisors reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
Calamos Advisors sold 59,143 STAAR Surgical shares in Q4 2022, an estimated $4.17M.
Calamos Advisors first reported a position in STAAR Surgical in Q1 2014 and held it in 14 quarters.
Calamos Advisors's STAAR Surgical position peaked at $5.86M in Q3 2021.
275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.